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tive (a-CTX) and age-modified (b-CTX) collagen type I fragments 
in decalcified, collagenase treated old and young bone slices. Im- 
munocytochemistry and ELISA were used to localize and quantify 
b-CTX and a-CTX release by osteoclasts on either young or old 
bone slices. 
Results: On young bone slices the formation of osteoclasts from 
osteoclast precursors was reduced by more than 50% compared 
to those formed on old bone (p<0.001). Osteoclastic resorption, 
as measured by b-CTX, was also reduced by more than 50% 
on young compared to old bone (p<0.001). By counting of the 
number of osteoclasts, old bones were shown to have 5 times as 
many osteoclasts as young bone (p<0.001). Osteoclast survival 
was two times higher on old bone than on young bone. Osteo- 
clasts adhered to young and old bone at equal rates. Cortical 
bone slices from old cows contained 3 times lower a-CTX/b-CTX 
ratios than those from young bones (p<0.01), further emphasiz- 
ing the quantitative difference between young and old bone. Dur- 
ing resorption the osteoclasts release a and b-CTX from both 
bone types, however, the a to b-CTX ratio is higher on young 
than old bones, whereas the total resorption level is higher on the 
old bones, indicating that osteoclasts preferentially degrade old 
bones. 
Conclusion: These data clearly show that old bones support 
osteoclastogenesis and osteoclast survival better than young 
bones. Hence, osteoclastic bone resorption on old bone is highly 
increased compared to that on young bone. Thus, the age of the 
bones might play instrumental role(s) in controlling the amount of 
resorption and thereby lead to targeted remodeling of old bones 
during the remodeling process. 
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Bone tissue homeostasis is a complex process that involves 
bone cells (i.e. osteoblasts and osteoclasts) and secreted fac- 
tors (i.e. hormones, cytokines). Evidence indicates that the pro- 
gression of joint cartilage degeneration in osteoarthritis (OA) is 
associated with subchondral bone modification. In OA patients, 
bone modifications are characterized by areas of subchondral 
sclerosis, enhanced bone density, increased subchondral bone 
metabolism, as well as increased collagen type I synthesis and 
osteophyte formations. Imbalance between osteoblast (OBs) and 
osteoclast functions as well as secretion of proinflammatory c - 
tokines, degradative nzymes and chemokines are responsible 
for bone tissue remodeling. 
To evaluate the role of CXC chemokines, CXCL8 (IL8), CXCL10 
(IP-10), CXCL12 (SDF-1) and CXCL13 (BCA-1) in bone remod- 
eling, we analysed their effects on osteoblasts obtained from 
subchondral trabecular bone tissue of osteoarthritis (OA) and 
post-traumatic (PT) patients. OBs were isolated and the expres- 
sion of CXC receptors/ligands (CXCR1/CXCL8, CXCR2/CXCL8, 
CXCR3/CXCL10, CXCR4/CXCL12, CXCR5/CXCL13) was anal- 
ysed by flow cytometry and immunocytochemistry. Functional as- 
says on CXC chemokine-treated-OBs in the presence or absence 
of their specific inhibitors were performed to analyse cellular pro- 
liferation and the enzymatic response to chemokine activation. 
The expression of chemokine ligands/receptors was also con- 
firmed in bone tissue samples by immunohistochemical naly- 
sis. Collagen type I and alkaline phosphatase mRNA expression 
were analysed on CXCL12- and CXCL13-treated OBs by Real- 
time PCR. 
OBs from both OA and PT patients expressed high levels of 
CXCR3 and CXCR5 and lower amounts of CXCR1 and CXCR4. 
CXCL12 and CXCL13, only in OBs from OA patients, induced a 
significant proliferation that was also confirmed by specific block- 
ing experiments. Moreover, OBs from OA patients released a 
higher amount of CXCL13 than those of PT patients while no 
differences were found for CXCL12. In the remodeling area of 
bone tissue samples, immunohistochemical nalysis confirmed 
that OBs expressed CXCL12/CXCR4 and CXCL13/CXCR5 both 
in OA and PT samples. CXCL12 and CXCL13 upregulated colla- 
gen type I mRNA expression in OBs from OA patients. 
These data suggest that CXCL12 and CXCL13 may directly mod- 
ulate cellular proliferation and collagen type I in OA patients, so 
contributing to the remodeling process that occurs in the evolution 
of this disease. 
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Aim: To profile degradative gene expression (MMP-1, 3, -13, 
ADAMTS-4 & -5, TIMP-1, -2, & -3) in chondrocytes from cartilage 
obtained from joints of normal and osteoarthritic (OA) horses. In 
particular to identify whether there is variation in gene expression 
with age in normal joints, as well as to document variations in 
such gene expression in different stages of OA. Furthermore to 
identify whether there are site specific variations in gene expres- 
sion between sites undergoing different loading in both normal 
and OA joints. 
Materials and Methods: Cartilage was obtained from low and 
high loaded sites of the medial femoral condyle of 15 normal 
horses aged 4-35 years old following euthanasia. Similar carti- 
lage samples were obtained form horses with acute traumatic OA 
(<3 month duration) (n=12) and Chronic OA (>3 months) (n=17). 
RNA was extracted and global cDNA libraries synthesised. Gene 
expression for relevant genes was quantified using Real Time 
PCR and normalised against GAPDH. Statistical analysis to as- 
sess the effect of age, site and disease state was performed using 
mixed effect linear regression models. 
Results: In normal joints, there was little difference in gene ex- 
pression between cartilage obtained from different loaded sites 
in the joint. There was a small but significant increase in MMP- 
13 (p<0.01) gene expression associated with increasing age. In 
OA samples there were no significant differences in any gene 
expression levels between different loaded sites within the joint. 
There were obvious perturbations in gene expression between 
normal and OA joints for a variety of genes. MMP-1 was in- 
creased (p<0.01) in acute (but not in chronic) OA, whilst MMP-3 
showed no significant difference between normal and either OA 
groups. MMP-13 was significantly increased in both acute and 
chronic OA (p<0.0001). ADAMTS-4 was significantly higher in 
both disease states, whilst ADAMTS-5 was significantly lower 
in both disease states (p<0.001). TIMP-1 was significantly up- 
regulated in both OA states (p<0.001), whilst TIMP-2 was sig- 
nificantly lower in both OA states (p<0.001). TI MP-3 was signifi- 
cantly lower in acute OA alone (p<0.01). 
Conclusion: There is little variation in degradative gene expres- 
sion with ageing in normal skeletally mature horses. In both acute 
and chronic OA there are considerable perturbations in gene ex- 
pression in comparison with normal joints, although some genes 
with similar functions are not co-regulated and show opposite 
